華為前軟件副總裁謝炎加入理想-W(02015.HK)系統研發部
《36氪》引述知情人士報道,華為前消費者BG軟件部副總裁、終端OS部部長謝炎,已入職理想汽車(02015.HK)(LI.US),出任系統研發部負責人,職級位列M11,僅次於理想汽車創始人兼行政總裁李想的M12。
謝炎負責的理想汽車系統研發部,主要是一些底層智能化技術研發,包括自研的操作系統、算力平台等。報道指,理想汽車的算力平台業務還包括了自研智能駕駛芯片項目,而此自研芯片項目團隊規模已有數十人,且有明確的時間表量產。
消息指,目前謝炎已經快速投入在業務上,和各個研發條線開會,聽取需求。理想汽車向報道表示不予置評。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.